Newman Brian 4

What Happened

• Brian Newman, Chief Financial Officer of CVS Health Corp (CVS), received two equity awards on 2026-03-31: 19,493 restricted stock units (RSUs) valued at $1,399,987 and a derivative award of 125,748 shares (stock option award) valued at $9,031,221. Both awards are reported at $71.82 per share. This was an employment/compensation grant (award), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-31; Form 4 filed: 2026-04-02 (filed two days after the transaction).
• Price used for valuation: $71.82 per share.
• Total shares granted: 145,241 (19,493 RSUs + 125,748 derivative option shares); total reported value: $10,431,208.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes:
  • F1: The 19,493 units are RSUs under the 2017 Incentive Compensation Plan; restrictions lapse in three equal installments beginning 3/31/2027.
  • F2: The 125,748 derivative award is an option that becomes exercisable in three equal annual installments beginning 3/31/2027.
• Transaction code: A = Award/Grant.

Context

• These entries are compensation grants—RSUs vest over time and the option award vests/exercisable in installments—so they do not represent an immediate cash transaction or sale. Such grants are routine for executive compensation and do not by themselves indicate insider buying or selling intent.